BOSTON, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing…
ESO’s research looks at documented fire decontamination practices, discovers almost one in five firefighters with no decontamination procedures documented following…
Partnership to Include Integration of Hologic Products, Specifically Designed for Gynecologic Care, into Hands-On Skills Education for OB-GYN ResidentsMARLBOROUGH, Mass.--(BUSINESS…
Canalevia®-CA1 is the first and only treatment for CID in dogs to receive any type of approval from the FDASAN…
Preclinical Data Demonstrate CBX-15's Anti-Tumor Efficacy in Animal Models and Ability to Enhance Immunogenicity and Induce Immune Memory through pH-Based…
LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), an advanced, pre-clinical biotechnology firm in cell,…
MADISON, Wis., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Stem Pharm, Inc., a drug discovery platform company leveraging 3D neuro-immune organoids…
- In our study, encaleret restored physiologic mineral homeostasis in 13 participants with ADH1, specifically correcting hypocalcemia and reducing hypercalciuria…
Submitted abstract on CAB-AXL-ADC, BA3011, in non-small cell lung cancer (NSCLC) to the IASLC 2023 North America Conference on Lung…
Dr. Gardner brings over 30 years of experience leading clinical development to support innovative oncology programs and translational research at…